Related references
Note: Only part of the references are listed.Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes
Assiamira Ferrara et al.
DIABETES CARE (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
Association Between Smoking and Risk of Bladder Cancer Among Men and Women
Neal D. Freedman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Diabetes mellitus, hyperglycaemia and cancer
D. Simon et al.
DIABETES & METABOLISM (2010)
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin-Latry et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
French national health insurance information system and the permanent beneficiaries sample
P. Tuppin et al.
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE (2010)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive
John Dormandy et al.
DRUG SAFETY (2009)
The effect of smoking on the male excess of bladder cancer: A meta-analysis and geographical analyses
Marjolein Hemelt et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Diabetes mellitus and risk of bladder cancer: a meta-analysis
S. C. Larsson et al.
DIABETOLOGIA (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action
Mark A. Dominick et al.
TOXICOLOGIC PATHOLOGY (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists
R Yoshimura et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Share Paper
